47.96
price up icon0.38%   0.18
 
loading

Sanofi Adr Aktie (SNY) Neueste Nachrichten

pulisher
Nov 20, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 20, 2024
pulisher
Nov 15, 2024

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease - Benzinga

Nov 15, 2024
pulisher
Nov 12, 2024

Communiqué de presse - GlobeNewswire Inc.

Nov 12, 2024
pulisher
Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Oct 30, 2024

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Oct 30, 2024
pulisher
Oct 30, 2024

Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register

Oct 30, 2024
pulisher
Oct 28, 2024

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

16 New 4-Star Stocks - Morningstar

Oct 28, 2024
pulisher
Oct 27, 2024

Sanofi SA (ADR: SNY) Stock Price Could Reach $63: Morningstar Research - TopNews India

Oct 27, 2024
pulisher
Oct 27, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 27, 2024
pulisher
Oct 25, 2024

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat - Investor's Business Daily

Oct 25, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup - Investing.com

Oct 24, 2024
pulisher
Oct 21, 2024

Sanofi Deal Jitters Imperil Stock’s Big Rebound - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale - Zacks Investment Research

Oct 21, 2024
pulisher
Oct 21, 2024

Proactive news headlines: Ananda, Helix Exploration, Deltic, Light Science Technologies and more - Proactive Investors UK

Oct 21, 2024
pulisher
Oct 21, 2024

French govt set to take stake in Sanofi unit after PE sale - Proactive Investors Australia

Oct 21, 2024
pulisher
Oct 21, 2024

Sanofi Negotiating Exclusively With CD&R For Opella 50% Stake Sale - Barchart

Oct 21, 2024
pulisher
Oct 15, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 14, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Oct 14, 2024
pulisher
Oct 10, 2024

Sanofi ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Oct 10, 2024
pulisher
Oct 09, 2024

Ratios Reveal: Breaking Down Sanofi ADR (SNY)’s Financial Health - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

EXK (Endeavour Silver Corp.) may reap gains as insiders became active recently - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Checking in on Clear Channel Outdoor Holdings Inc. (CCO) after recent insiders movement - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Sanofi ADR (SNY): What You Must Know - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

An Analysis of KE Holdings Inc ADR (BEKE)’s Potential Price Growth - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Europe Pruritus Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024
pulisher
Oct 08, 2024

OTC Drug and Dietary Supplement Market Opportunities and Strategies to 2033 - GlobeNewswire Inc.

Oct 08, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024
drug_manufacturers_general BMY
$58.09
price up icon 0.40%
drug_manufacturers_general PFE
$24.95
price up icon 0.04%
$290.00
price up icon 0.60%
drug_manufacturers_general NVS
$103.85
price up icon 0.72%
drug_manufacturers_general MRK
$99.47
price up icon 2.05%
Kapitalisierung:     |  Volumen (24h):